| Nathan Avery, MD | |
|
16233 Sylvester Rd Sw Ste 110, Burien, WA 98166-3044 | |
| (206) 901-8980 | |
| Not Available |
| Full Name | Nathan Avery |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 13 Years |
| Location | 16233 Sylvester Rd Sw Ste 110, Burien, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417256132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD60764803 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highline Medical Center | Burien, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
People who misuse prescription pain relievers all have one thing in common, University of Georgia researchers have discovered: a history of recent illicit drug use. How they acquire such drugs varies according to age, however.
Family doctors should offer men with erectile dysfunction treatment with a statin – not only to improve their quality of life but also to reduce their future cardiovascular risk.
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
› Verified 6 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
People who misuse prescription pain relievers all have one thing in common, University of Georgia researchers have discovered: a history of recent illicit drug use. How they acquire such drugs varies according to age, however.
Family doctors should offer men with erectile dysfunction treatment with a statin – not only to improve their quality of life but also to reduce their future cardiovascular risk.
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Avery, MD 16233 Sylvester Rd Sw Ste 110, Burien, WA 98166-3044 Ph: (206) 901-8980 | Nathan Avery, MD 16233 Sylvester Rd Sw Ste 110, Burien, WA 98166-3044 Ph: (206) 901-8980 |
News Archive
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
People who misuse prescription pain relievers all have one thing in common, University of Georgia researchers have discovered: a history of recent illicit drug use. How they acquire such drugs varies according to age, however.
Family doctors should offer men with erectile dysfunction treatment with a statin – not only to improve their quality of life but also to reduce their future cardiovascular risk.
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
› Verified 6 days ago
Dr. Michael M Kennelly, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw Ste 110, Burien, WA 98166 Phone: 206-901-8980 | |
Mr. Vincent Nnaemeka Muoneke, MD Surgery Medicare: Medicare Enrolled Practice Location: 16233 Sylvester Rd Sw, Suite280, Burien, WA 98166 Phone: 206-248-6992 Fax: 253-984-6774 | |
Marco A. Sobrino, M.D., F.A.C.S. Surgery Medicare: Medicare Enrolled Practice Location: 16122 8th Ave Sw, Suite D1, Burien, WA 98166 Phone: 206-244-1680 Fax: 206-243-8845 | |
Erina Kansakar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw Ste 110, Burien, WA 98166 Phone: 206-901-8980 Fax: 253-426-6344 |